rct
    2007
    High Quality

    Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women

    Bolton-Smith C, McMurdo ME, Paterson CR, Mole PA, Harvey JM, Fenton ST, et al.

    Published in J Bone Miner Res, Vol. 22 (4), pp. 509-19

    Methodology

    Two-year double-blind, placebo-controlled trial in 244 healthy, non-osteoporotic Scottish women aged 60 or over, randomised to placebo, 200 mcg/day vitamin K1, 400 IU vitamin D3 plus 1,000 mg calcium, or all three combined. Bone density and content of the hip and wrist by DXA.

    Key Findings

    Vitamin K1 alone did not change bone density at any site. Women taking vitamin K1 together with vitamin D3 and calcium had a significant, sustained rise in bone density and content at the ultradistal radius only, not at the hip. Vitamin K1 raised serum vitamin K1 by 157% and cut undercarboxylated osteocalcin by 51%.

    Conclusions

    The authors describe a modest synergy of vitamin K1 with calcium and vitamin D at one wrist site, and suggest the effect could be reached through diet rather than supplements.

    Limitations

    Healthy women without osteoporosis; benefit confined to one of several measured sites; no fracture outcomes.

    Supplements Studied

    Vitamin K1
    Vitamin

    a modest but significant increase in BMC at the ultradistal radius

    Vitamin D
    Vitamin

    10 microg (400 IU) vitamin D(3) plus 1000 mg calcium/day

    Calcium
    Mineral

    10 microg (400 IU) vitamin D(3) plus 1000 mg calcium/day

    Outcomes Measured

    a significant and sustained increase in both BMD and BMC at the site of the ultradistal radius

    Related Health Concerns

    Study Details

    Year:2007
    Sample Size:244
    Duration:104 weeks
    Quality Score:7/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.